nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PGR—ovarian cancer	0.418	0.788	CbGaD
Betamethasone—ABCB1—ovarian cancer	0.112	0.211	CbGaD
Betamethasone—CYP19A1—Paclitaxel—ovarian cancer	0.0713	0.341	CbGbCtD
Betamethasone—ABCB1—Topotecan—ovarian cancer	0.0304	0.146	CbGbCtD
Betamethasone—ABCB1—Vinorelbine—ovarian cancer	0.0214	0.103	CbGbCtD
Betamethasone—CYP3A4—Topotecan—ovarian cancer	0.0182	0.0874	CbGbCtD
Betamethasone—CYP19A1—follicular fluid—ovarian cancer	0.0152	0.166	CbGeAlD
Betamethasone—ABCB1—Paclitaxel—ovarian cancer	0.0151	0.0722	CbGbCtD
Betamethasone—CYP3A4—Vinorelbine—ovarian cancer	0.0128	0.0616	CbGbCtD
Betamethasone—ABCB1—Docetaxel—ovarian cancer	0.0109	0.0522	CbGbCtD
Betamethasone—PGR—corpus luteum—ovarian cancer	0.00976	0.106	CbGeAlD
Betamethasone—CYP3A4—Paclitaxel—ovarian cancer	0.00903	0.0432	CbGbCtD
Betamethasone—CYP19A1—corpus luteum—ovarian cancer	0.00878	0.0956	CbGeAlD
Betamethasone—ABCB1—Doxorubicin—ovarian cancer	0.00812	0.0389	CbGbCtD
Betamethasone—PGR—ovarian follicle—ovarian cancer	0.00763	0.0831	CbGeAlD
Betamethasone—CYP19A1—ovarian follicle—ovarian cancer	0.00687	0.0748	CbGeAlD
Betamethasone—CYP3A4—Docetaxel—ovarian cancer	0.00653	0.0313	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—ovarian cancer	0.00487	0.0233	CbGbCtD
Betamethasone—PTGS2—ovarian follicle—ovarian cancer	0.00381	0.0415	CbGeAlD
Betamethasone—PGR—oviduct—ovarian cancer	0.00335	0.0365	CbGeAlD
Betamethasone—PLA2G1B—epithelium—ovarian cancer	0.00183	0.0199	CbGeAlD
Betamethasone—PLA2G1B—female reproductive system—ovarian cancer	0.00136	0.0148	CbGeAlD
Betamethasone—PLA2G1B—female gonad—ovarian cancer	0.00124	0.0135	CbGeAlD
Betamethasone—NR3C2—myometrium—ovarian cancer	0.00115	0.0126	CbGeAlD
Betamethasone—PLA2G1B—testis—ovarian cancer	0.0011	0.0119	CbGeAlD
Betamethasone—PGR—myometrium—ovarian cancer	0.00107	0.0117	CbGeAlD
Betamethasone—NR3C2—uterine cervix—ovarian cancer	0.000898	0.00978	CbGeAlD
Betamethasone—PGR—epithelium—ovarian cancer	0.000842	0.00917	CbGeAlD
Betamethasone—PGR—uterine cervix—ovarian cancer	0.000835	0.00909	CbGeAlD
Betamethasone—NR3C2—endometrium—ovarian cancer	0.000812	0.00884	CbGeAlD
Betamethasone—PGR—decidua—ovarian cancer	0.000796	0.00866	CbGeAlD
Betamethasone—PGR—endometrium—ovarian cancer	0.000755	0.00822	CbGeAlD
Betamethasone—NR3C2—uterus—ovarian cancer	0.000749	0.00815	CbGeAlD
Betamethasone—PGR—uterus—ovarian cancer	0.000696	0.00757	CbGeAlD
Betamethasone—CYP19A1—endometrium—ovarian cancer	0.00068	0.0074	CbGeAlD
Betamethasone—NR3C2—female reproductive system—ovarian cancer	0.000673	0.00732	CbGeAlD
Betamethasone—CYP19A1—gonad—ovarian cancer	0.00063	0.00686	CbGeAlD
Betamethasone—CYP19A1—uterus—ovarian cancer	0.000626	0.00682	CbGeAlD
Betamethasone—PGR—female reproductive system—ovarian cancer	0.000626	0.00681	CbGeAlD
Betamethasone—NR3C1—myometrium—ovarian cancer	0.000619	0.00674	CbGeAlD
Betamethasone—NR3C2—female gonad—ovarian cancer	0.000612	0.00667	CbGeAlD
Betamethasone—NR3C2—vagina—ovarian cancer	0.000609	0.00662	CbGeAlD
Betamethasone—NR3C1—embryo—ovarian cancer	0.000596	0.00648	CbGeAlD
Betamethasone—PGR—female gonad—ovarian cancer	0.000569	0.0062	CbGeAlD
Betamethasone—PGR—vagina—ovarian cancer	0.000566	0.00616	CbGeAlD
Betamethasone—CYP19A1—female reproductive system—ovarian cancer	0.000563	0.00613	CbGeAlD
Betamethasone—NR3C2—testis—ovarian cancer	0.000543	0.00591	CbGeAlD
Betamethasone—PTGS2—myometrium—ovarian cancer	0.000536	0.00583	CbGeAlD
Betamethasone—PTGS2—embryo—ovarian cancer	0.000515	0.00561	CbGeAlD
Betamethasone—CYP19A1—female gonad—ovarian cancer	0.000512	0.00558	CbGeAlD
Betamethasone—PGR—testis—ovarian cancer	0.000505	0.0055	CbGeAlD
Betamethasone—NR3C1—epithelium—ovarian cancer	0.000486	0.00529	CbGeAlD
Betamethasone—NR3C1—uterine cervix—ovarian cancer	0.000482	0.00524	CbGeAlD
Betamethasone—NR3C1—decidua—ovarian cancer	0.000459	0.005	CbGeAlD
Betamethasone—CYP19A1—testis—ovarian cancer	0.000454	0.00495	CbGeAlD
Betamethasone—NR3C1—endometrium—ovarian cancer	0.000436	0.00474	CbGeAlD
Betamethasone—PTGS2—epithelium—ovarian cancer	0.000421	0.00458	CbGeAlD
Betamethasone—PTGS2—uterine cervix—ovarian cancer	0.000417	0.00454	CbGeAlD
Betamethasone—NR3C1—gonad—ovarian cancer	0.000404	0.0044	CbGeAlD
Betamethasone—NR3C1—uterus—ovarian cancer	0.000402	0.00437	CbGeAlD
Betamethasone—NR3C2—lymph node—ovarian cancer	0.000394	0.00428	CbGeAlD
Betamethasone—PTGS2—endometrium—ovarian cancer	0.000377	0.0041	CbGeAlD
Betamethasone—PGR—lymph node—ovarian cancer	0.000366	0.00398	CbGeAlD
Betamethasone—NR3C1—female reproductive system—ovarian cancer	0.000361	0.00393	CbGeAlD
Betamethasone—PTGS2—uterus—ovarian cancer	0.000348	0.00378	CbGeAlD
Betamethasone—NR3C1—bone marrow—ovarian cancer	0.000341	0.00371	CbGeAlD
Betamethasone—ABCB1—myometrium—ovarian cancer	0.000331	0.00361	CbGeAlD
Betamethasone—Fluticasone Propionate—PGR—ovarian cancer	0.000331	0.226	CrCbGaD
Betamethasone—CYP19A1—lymph node—ovarian cancer	0.000329	0.00358	CbGeAlD
Betamethasone—NR3C1—female gonad—ovarian cancer	0.000328	0.00358	CbGeAlD
Betamethasone—NR3C1—vagina—ovarian cancer	0.000326	0.00355	CbGeAlD
Betamethasone—ABCB1—embryo—ovarian cancer	0.000319	0.00347	CbGeAlD
Betamethasone—PTGS2—female reproductive system—ovarian cancer	0.000312	0.0034	CbGeAlD
Betamethasone—PTGS2—bone marrow—ovarian cancer	0.000295	0.00321	CbGeAlD
Betamethasone—NR3C1—testis—ovarian cancer	0.000291	0.00317	CbGeAlD
Betamethasone—PTGS2—female gonad—ovarian cancer	0.000284	0.00309	CbGeAlD
Betamethasone—PTGS2—vagina—ovarian cancer	0.000283	0.00308	CbGeAlD
Betamethasone—CYP3A4—female reproductive system—ovarian cancer	0.000273	0.00297	CbGeAlD
Betamethasone—ABCB1—epithelium—ovarian cancer	0.00026	0.00283	CbGeAlD
Betamethasone—ABCB1—uterine cervix—ovarian cancer	0.000258	0.00281	CbGeAlD
Betamethasone—ABCB1—decidua—ovarian cancer	0.000246	0.00267	CbGeAlD
Betamethasone—Fluoxymesterone—ESR1—ovarian cancer	0.000246	0.167	CrCbGaD
Betamethasone—ABCB1—endometrium—ovarian cancer	0.000233	0.00254	CbGeAlD
Betamethasone—ABCB1—gonad—ovarian cancer	0.000216	0.00236	CbGeAlD
Betamethasone—ABCB1—uterus—ovarian cancer	0.000215	0.00234	CbGeAlD
Betamethasone—NR3C1—lymph node—ovarian cancer	0.000211	0.0023	CbGeAlD
Betamethasone—ABCB1—female reproductive system—ovarian cancer	0.000193	0.0021	CbGeAlD
Betamethasone—PTGS2—lymph node—ovarian cancer	0.000183	0.00199	CbGeAlD
Betamethasone—ABCB1—bone marrow—ovarian cancer	0.000182	0.00199	CbGeAlD
Betamethasone—Dexamethasone—PGR—ovarian cancer	0.000176	0.12	CrCbGaD
Betamethasone—ABCB1—female gonad—ovarian cancer	0.000176	0.00191	CbGeAlD
Betamethasone—ABCB1—vagina—ovarian cancer	0.000175	0.0019	CbGeAlD
Betamethasone—Dexamethasone—CYP1B1—ovarian cancer	0.000165	0.112	CrCbGaD
Betamethasone—ABCB1—testis—ovarian cancer	0.000156	0.0017	CbGeAlD
Betamethasone—Fluticasone furoate—ABCB1—ovarian cancer	0.000148	0.101	CrCbGaD
Betamethasone—Pruritus—Melphalan—ovarian cancer	0.000127	0.00111	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000127	0.0011	CcSEcCtD
Betamethasone—Haemoglobin—Docetaxel—ovarian cancer	0.000127	0.0011	CcSEcCtD
Betamethasone—Haemorrhage—Docetaxel—ovarian cancer	0.000126	0.0011	CcSEcCtD
Betamethasone—Eye pain—Doxorubicin—ovarian cancer	0.000126	0.0011	CcSEcCtD
Betamethasone—Cardiac failure—Epirubicin—ovarian cancer	0.000126	0.0011	CcSEcCtD
Betamethasone—Diarrhoea—Topotecan—ovarian cancer	0.000126	0.00109	CcSEcCtD
Betamethasone—Lethargy—Epirubicin—ovarian cancer	0.000126	0.00109	CcSEcCtD
Betamethasone—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000126	0.00109	CcSEcCtD
Betamethasone—Urticaria—Vinorelbine—ovarian cancer	0.000125	0.00109	CcSEcCtD
Betamethasone—Body temperature increased—Vinorelbine—ovarian cancer	0.000124	0.00108	CcSEcCtD
Betamethasone—Abdominal pain—Vinorelbine—ovarian cancer	0.000124	0.00108	CcSEcCtD
Betamethasone—Diarrhoea—Melphalan—ovarian cancer	0.000123	0.00107	CcSEcCtD
Betamethasone—Osteoarthritis—Epirubicin—ovarian cancer	0.000123	0.00107	CcSEcCtD
Betamethasone—Nausea—Chlorambucil—ovarian cancer	0.000123	0.00107	CcSEcCtD
Betamethasone—Visual impairment—Docetaxel—ovarian cancer	0.000122	0.00106	CcSEcCtD
Betamethasone—Dizziness—Topotecan—ovarian cancer	0.000122	0.00106	CcSEcCtD
Betamethasone—Increased appetite—Doxorubicin—ovarian cancer	0.000121	0.00105	CcSEcCtD
Betamethasone—Affect lability—Epirubicin—ovarian cancer	0.000121	0.00105	CcSEcCtD
Betamethasone—Migraine—Epirubicin—ovarian cancer	0.000121	0.00105	CcSEcCtD
Betamethasone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00012	0.00104	CcSEcCtD
Betamethasone—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000119	0.00103	CcSEcCtD
Betamethasone—Angioedema—Paclitaxel—ovarian cancer	0.000118	0.00103	CcSEcCtD
Betamethasone—Eye disorder—Docetaxel—ovarian cancer	0.000118	0.00102	CcSEcCtD
Betamethasone—Methylprednisolone—ABCB1—ovarian cancer	0.000118	0.0803	CrCbGaD
Betamethasone—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000118	0.00102	CcSEcCtD
Betamethasone—Cardiac arrest—Epirubicin—ovarian cancer	0.000117	0.00102	CcSEcCtD
Betamethasone—Vomiting—Topotecan—ovarian cancer	0.000117	0.00102	CcSEcCtD
Betamethasone—Malaise—Paclitaxel—ovarian cancer	0.000117	0.00102	CcSEcCtD
Betamethasone—Cardiac failure—Doxorubicin—ovarian cancer	0.000117	0.00101	CcSEcCtD
Betamethasone—Mood swings—Epirubicin—ovarian cancer	0.000117	0.00101	CcSEcCtD
Betamethasone—Vertigo—Paclitaxel—ovarian cancer	0.000116	0.00101	CcSEcCtD
Betamethasone—Syncope—Paclitaxel—ovarian cancer	0.000116	0.00101	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—ovarian cancer	0.000116	0.00101	CcSEcCtD
Betamethasone—Rash—Topotecan—ovarian cancer	0.000116	0.00101	CcSEcCtD
Betamethasone—Dermatitis—Topotecan—ovarian cancer	0.000116	0.00101	CcSEcCtD
Betamethasone—Headache—Topotecan—ovarian cancer	0.000115	0.001	CcSEcCtD
Betamethasone—Angiopathy—Docetaxel—ovarian cancer	0.000114	0.000995	CcSEcCtD
Betamethasone—Vomiting—Melphalan—ovarian cancer	0.000114	0.000994	CcSEcCtD
Betamethasone—Loss of consciousness—Paclitaxel—ovarian cancer	0.000114	0.00099	CcSEcCtD
Betamethasone—Osteoarthritis—Doxorubicin—ovarian cancer	0.000114	0.000989	CcSEcCtD
Betamethasone—Rash—Melphalan—ovarian cancer	0.000113	0.000986	CcSEcCtD
Betamethasone—Dermatitis—Melphalan—ovarian cancer	0.000113	0.000985	CcSEcCtD
Betamethasone—ABCB1—lymph node—ovarian cancer	0.000113	0.00123	CbGeAlD
Betamethasone—Asthenia—Vinorelbine—ovarian cancer	0.000113	0.00098	CcSEcCtD
Betamethasone—Dry skin—Epirubicin—ovarian cancer	0.000113	0.00098	CcSEcCtD
Betamethasone—Arrhythmia—Docetaxel—ovarian cancer	0.000113	0.000979	CcSEcCtD
Betamethasone—Convulsion—Paclitaxel—ovarian cancer	0.000112	0.000976	CcSEcCtD
Betamethasone—Migraine—Doxorubicin—ovarian cancer	0.000112	0.000973	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—ovarian cancer	0.000112	0.000973	CcSEcCtD
Betamethasone—Hypokalaemia—Epirubicin—ovarian cancer	0.000112	0.000973	CcSEcCtD
Betamethasone—Hypertension—Paclitaxel—ovarian cancer	0.000112	0.000972	CcSEcCtD
Betamethasone—Alopecia—Docetaxel—ovarian cancer	0.000112	0.000969	CcSEcCtD
Betamethasone—Pruritus—Vinorelbine—ovarian cancer	0.000111	0.000967	CcSEcCtD
Betamethasone—Myalgia—Paclitaxel—ovarian cancer	0.00011	0.000959	CcSEcCtD
Betamethasone—Anxiety—Paclitaxel—ovarian cancer	0.00011	0.000955	CcSEcCtD
Betamethasone—Erythema—Docetaxel—ovarian cancer	0.00011	0.000954	CcSEcCtD
Betamethasone—Nausea—Topotecan—ovarian cancer	0.000109	0.000949	CcSEcCtD
Betamethasone—Discomfort—Paclitaxel—ovarian cancer	0.000109	0.000947	CcSEcCtD
Betamethasone—Muscular weakness—Epirubicin—ovarian cancer	0.000109	0.000943	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—ovarian cancer	0.000108	0.00094	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—ovarian cancer	0.000108	0.000937	CcSEcCtD
Betamethasone—Diarrhoea—Vinorelbine—ovarian cancer	0.000108	0.000935	CcSEcCtD
Betamethasone—Nausea—Melphalan—ovarian cancer	0.000107	0.000929	CcSEcCtD
Betamethasone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000106	0.000919	CcSEcCtD
Betamethasone—Oedema—Paclitaxel—ovarian cancer	0.000106	0.000919	CcSEcCtD
Betamethasone—Infection—Paclitaxel—ovarian cancer	0.000105	0.000913	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—ovarian cancer	0.000104	0.000907	CcSEcCtD
Betamethasone—Shock—Paclitaxel—ovarian cancer	0.000104	0.000904	CcSEcCtD
Betamethasone—Dizziness—Vinorelbine—ovarian cancer	0.000104	0.000903	CcSEcCtD
Betamethasone—Nervous system disorder—Paclitaxel—ovarian cancer	0.000104	0.000901	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—ovarian cancer	0.000104	0.0009	CcSEcCtD
Betamethasone—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000104	0.0009	CcSEcCtD
Betamethasone—Tachycardia—Paclitaxel—ovarian cancer	0.000103	0.000897	CcSEcCtD
Betamethasone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000102	0.000888	CcSEcCtD
Betamethasone—Anorexia—Paclitaxel—ovarian cancer	0.000101	0.000876	CcSEcCtD
Betamethasone—Muscular weakness—Doxorubicin—ovarian cancer	0.0001	0.000872	CcSEcCtD
Betamethasone—Vomiting—Vinorelbine—ovarian cancer	0.0001	0.000869	CcSEcCtD
Betamethasone—Rash—Vinorelbine—ovarian cancer	9.91e-05	0.000861	CcSEcCtD
Betamethasone—Dermatitis—Vinorelbine—ovarian cancer	9.91e-05	0.000861	CcSEcCtD
Betamethasone—Hypotension—Paclitaxel—ovarian cancer	9.88e-05	0.000859	CcSEcCtD
Betamethasone—Headache—Vinorelbine—ovarian cancer	9.85e-05	0.000856	CcSEcCtD
Betamethasone—Syncope—Docetaxel—ovarian cancer	9.85e-05	0.000856	CcSEcCtD
Betamethasone—Weight increased—Epirubicin—ovarian cancer	9.68e-05	0.000841	CcSEcCtD
Betamethasone—Loss of consciousness—Docetaxel—ovarian cancer	9.65e-05	0.000839	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	9.64e-05	0.000837	CcSEcCtD
Betamethasone—Weight decreased—Epirubicin—ovarian cancer	9.62e-05	0.000836	CcSEcCtD
Betamethasone—Hyperglycaemia—Epirubicin—ovarian cancer	9.59e-05	0.000833	CcSEcCtD
Betamethasone—Insomnia—Paclitaxel—ovarian cancer	9.57e-05	0.000831	CcSEcCtD
Betamethasone—Convulsion—Docetaxel—ovarian cancer	9.52e-05	0.000827	CcSEcCtD
Betamethasone—Paraesthesia—Paclitaxel—ovarian cancer	9.5e-05	0.000825	CcSEcCtD
Betamethasone—Hypertension—Docetaxel—ovarian cancer	9.48e-05	0.000824	CcSEcCtD
Betamethasone—Myalgia—Docetaxel—ovarian cancer	9.35e-05	0.000812	CcSEcCtD
Betamethasone—Nausea—Vinorelbine—ovarian cancer	9.34e-05	0.000811	CcSEcCtD
Betamethasone—Dyspepsia—Paclitaxel—ovarian cancer	9.31e-05	0.000809	CcSEcCtD
Betamethasone—Neuropathy peripheral—Epirubicin—ovarian cancer	9.29e-05	0.000807	CcSEcCtD
Betamethasone—Conjunctivitis—Epirubicin—ovarian cancer	9.22e-05	0.000801	CcSEcCtD
Betamethasone—Decreased appetite—Paclitaxel—ovarian cancer	9.19e-05	0.000799	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	9.13e-05	0.000793	CcSEcCtD
Betamethasone—Fatigue—Paclitaxel—ovarian cancer	9.12e-05	0.000792	CcSEcCtD
Betamethasone—Pain—Paclitaxel—ovarian cancer	9.04e-05	0.000786	CcSEcCtD
Betamethasone—Prednisone—ABCB1—ovarian cancer	9e-05	0.0614	CrCbGaD
Betamethasone—Oedema—Docetaxel—ovarian cancer	8.96e-05	0.000779	CcSEcCtD
Betamethasone—Anaphylactic shock—Docetaxel—ovarian cancer	8.96e-05	0.000779	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—ovarian cancer	8.95e-05	0.000778	CcSEcCtD
Betamethasone—Infection—Docetaxel—ovarian cancer	8.91e-05	0.000774	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—ovarian cancer	8.9e-05	0.000773	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—ovarian cancer	8.87e-05	0.000771	CcSEcCtD
Betamethasone—Shock—Docetaxel—ovarian cancer	8.82e-05	0.000766	CcSEcCtD
Betamethasone—Nervous system disorder—Docetaxel—ovarian cancer	8.79e-05	0.000764	CcSEcCtD
Betamethasone—Thrombocytopenia—Docetaxel—ovarian cancer	8.78e-05	0.000763	CcSEcCtD
Betamethasone—Tachycardia—Docetaxel—ovarian cancer	8.75e-05	0.00076	CcSEcCtD
Betamethasone—Feeling abnormal—Paclitaxel—ovarian cancer	8.72e-05	0.000757	CcSEcCtD
Betamethasone—Bradycardia—Epirubicin—ovarian cancer	8.66e-05	0.000753	CcSEcCtD
Betamethasone—Gastrointestinal pain—Paclitaxel—ovarian cancer	8.65e-05	0.000751	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—ovarian cancer	8.6e-05	0.000747	CcSEcCtD
Betamethasone—Haemoglobin—Epirubicin—ovarian cancer	8.55e-05	0.000743	CcSEcCtD
Betamethasone—Anorexia—Docetaxel—ovarian cancer	8.55e-05	0.000742	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—ovarian cancer	8.53e-05	0.000741	CcSEcCtD
Betamethasone—Haemorrhage—Epirubicin—ovarian cancer	8.51e-05	0.000739	CcSEcCtD
Betamethasone—Urticaria—Paclitaxel—ovarian cancer	8.4e-05	0.00073	CcSEcCtD
Betamethasone—Hypotension—Docetaxel—ovarian cancer	8.38e-05	0.000728	CcSEcCtD
Betamethasone—Abdominal pain—Paclitaxel—ovarian cancer	8.36e-05	0.000726	CcSEcCtD
Betamethasone—Body temperature increased—Paclitaxel—ovarian cancer	8.36e-05	0.000726	CcSEcCtD
Betamethasone—Prednisolone—ABCB1—ovarian cancer	8.3e-05	0.0566	CrCbGaD
Betamethasone—Visual impairment—Epirubicin—ovarian cancer	8.2e-05	0.000713	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	8.17e-05	0.00071	CcSEcCtD
Betamethasone—Insomnia—Docetaxel—ovarian cancer	8.11e-05	0.000704	CcSEcCtD
Betamethasone—Paraesthesia—Docetaxel—ovarian cancer	8.05e-05	0.000699	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—ovarian cancer	8.02e-05	0.000697	CcSEcCtD
Betamethasone—Eye disorder—Epirubicin—ovarian cancer	7.95e-05	0.000691	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—ovarian cancer	7.91e-05	0.000688	CcSEcCtD
Betamethasone—Dyspepsia—Docetaxel—ovarian cancer	7.89e-05	0.000686	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—ovarian cancer	7.87e-05	0.000684	CcSEcCtD
Betamethasone—Decreased appetite—Docetaxel—ovarian cancer	7.79e-05	0.000677	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Docetaxel—ovarian cancer	7.74e-05	0.000672	CcSEcCtD
Betamethasone—Fatigue—Docetaxel—ovarian cancer	7.73e-05	0.000672	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—ovarian cancer	7.72e-05	0.000671	CcSEcCtD
Betamethasone—Pain—Docetaxel—ovarian cancer	7.67e-05	0.000666	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—ovarian cancer	7.6e-05	0.000661	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—ovarian cancer	7.59e-05	0.000659	CcSEcCtD
Betamethasone—Asthenia—Paclitaxel—ovarian cancer	7.59e-05	0.000659	CcSEcCtD
Betamethasone—Alopecia—Epirubicin—ovarian cancer	7.52e-05	0.000653	CcSEcCtD
Betamethasone—Pruritus—Paclitaxel—ovarian cancer	7.48e-05	0.00065	CcSEcCtD
Betamethasone—Erythema—Epirubicin—ovarian cancer	7.41e-05	0.000644	CcSEcCtD
Betamethasone—Feeling abnormal—Docetaxel—ovarian cancer	7.39e-05	0.000642	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—ovarian cancer	7.36e-05	0.000639	CcSEcCtD
Betamethasone—Gastrointestinal pain—Docetaxel—ovarian cancer	7.33e-05	0.000637	CcSEcCtD
Betamethasone—Diarrhoea—Paclitaxel—ovarian cancer	7.24e-05	0.000629	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—ovarian cancer	7.14e-05	0.000621	CcSEcCtD
Betamethasone—Abdominal pain—Docetaxel—ovarian cancer	7.09e-05	0.000616	CcSEcCtD
Betamethasone—Body temperature increased—Docetaxel—ovarian cancer	7.09e-05	0.000616	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—ovarian cancer	7.03e-05	0.000611	CcSEcCtD
Betamethasone—Dizziness—Paclitaxel—ovarian cancer	6.99e-05	0.000608	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—ovarian cancer	6.96e-05	0.000605	CcSEcCtD
Betamethasone—Ill-defined disorder—Epirubicin—ovarian cancer	6.87e-05	0.000597	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—ovarian cancer	6.86e-05	0.000596	CcSEcCtD
Betamethasone—Vomiting—Paclitaxel—ovarian cancer	6.72e-05	0.000584	CcSEcCtD
Betamethasone—Malaise—Epirubicin—ovarian cancer	6.68e-05	0.00058	CcSEcCtD
Betamethasone—Rash—Paclitaxel—ovarian cancer	6.67e-05	0.000579	CcSEcCtD
Betamethasone—Dermatitis—Paclitaxel—ovarian cancer	6.66e-05	0.000579	CcSEcCtD
Betamethasone—Vertigo—Epirubicin—ovarian cancer	6.66e-05	0.000578	CcSEcCtD
Betamethasone—Syncope—Epirubicin—ovarian cancer	6.64e-05	0.000577	CcSEcCtD
Betamethasone—Headache—Paclitaxel—ovarian cancer	6.63e-05	0.000576	CcSEcCtD
Betamethasone—Loss of consciousness—Epirubicin—ovarian cancer	6.51e-05	0.000566	CcSEcCtD
Betamethasone—Asthenia—Docetaxel—ovarian cancer	6.43e-05	0.000559	CcSEcCtD
Betamethasone—Convulsion—Epirubicin—ovarian cancer	6.42e-05	0.000558	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—ovarian cancer	6.4e-05	0.000556	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—ovarian cancer	6.36e-05	0.000553	CcSEcCtD
Betamethasone—Hydrocortisone—ABCB1—ovarian cancer	6.35e-05	0.0433	CrCbGaD
Betamethasone—Pruritus—Docetaxel—ovarian cancer	6.34e-05	0.000551	CcSEcCtD
Betamethasone—Myalgia—Epirubicin—ovarian cancer	6.31e-05	0.000548	CcSEcCtD
Betamethasone—Anxiety—Epirubicin—ovarian cancer	6.29e-05	0.000546	CcSEcCtD
Betamethasone—Nausea—Paclitaxel—ovarian cancer	6.28e-05	0.000546	CcSEcCtD
Betamethasone—Discomfort—Epirubicin—ovarian cancer	6.23e-05	0.000541	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—ovarian cancer	6.18e-05	0.000537	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—ovarian cancer	6.16e-05	0.000535	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—ovarian cancer	6.15e-05	0.000534	CcSEcCtD
Betamethasone—Diarrhoea—Docetaxel—ovarian cancer	6.13e-05	0.000533	CcSEcCtD
Betamethasone—Oedema—Epirubicin—ovarian cancer	6.05e-05	0.000525	CcSEcCtD
Betamethasone—Anaphylactic shock—Epirubicin—ovarian cancer	6.05e-05	0.000525	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—ovarian cancer	6.03e-05	0.000523	CcSEcCtD
Betamethasone—Infection—Epirubicin—ovarian cancer	6.01e-05	0.000522	CcSEcCtD
Betamethasone—Shock—Epirubicin—ovarian cancer	5.95e-05	0.000517	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—ovarian cancer	5.94e-05	0.000516	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—ovarian cancer	5.93e-05	0.000515	CcSEcCtD
Betamethasone—Dizziness—Docetaxel—ovarian cancer	5.93e-05	0.000515	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—ovarian cancer	5.92e-05	0.000514	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—ovarian cancer	5.92e-05	0.000514	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—ovarian cancer	5.9e-05	0.000513	CcSEcCtD
Betamethasone—Hyperhidrosis—Epirubicin—ovarian cancer	5.85e-05	0.000508	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—ovarian cancer	5.84e-05	0.000507	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—ovarian cancer	5.82e-05	0.000505	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—ovarian cancer	5.77e-05	0.000501	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—ovarian cancer	5.76e-05	0.000501	CcSEcCtD
Betamethasone—Vomiting—Docetaxel—ovarian cancer	5.7e-05	0.000495	CcSEcCtD
Betamethasone—Rash—Docetaxel—ovarian cancer	5.65e-05	0.000491	CcSEcCtD
Betamethasone—Hypotension—Epirubicin—ovarian cancer	5.65e-05	0.000491	CcSEcCtD
Betamethasone—Dermatitis—Docetaxel—ovarian cancer	5.65e-05	0.000491	CcSEcCtD
Betamethasone—Headache—Docetaxel—ovarian cancer	5.62e-05	0.000488	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—ovarian cancer	5.59e-05	0.000486	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—ovarian cancer	5.59e-05	0.000486	CcSEcCtD
Betamethasone—Infection—Doxorubicin—ovarian cancer	5.56e-05	0.000483	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	5.51e-05	0.000479	CcSEcCtD
Betamethasone—Shock—Doxorubicin—ovarian cancer	5.5e-05	0.000478	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—ovarian cancer	5.49e-05	0.000477	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—ovarian cancer	5.48e-05	0.000476	CcSEcCtD
Betamethasone—Insomnia—Epirubicin—ovarian cancer	5.47e-05	0.000475	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—ovarian cancer	5.46e-05	0.000474	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—ovarian cancer	5.43e-05	0.000472	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—ovarian cancer	5.41e-05	0.00047	CcSEcCtD
Betamethasone—Anorexia—Doxorubicin—ovarian cancer	5.33e-05	0.000463	CcSEcCtD
Betamethasone—Nausea—Docetaxel—ovarian cancer	5.32e-05	0.000463	CcSEcCtD
Betamethasone—Dyspepsia—Epirubicin—ovarian cancer	5.32e-05	0.000462	CcSEcCtD
Betamethasone—Decreased appetite—Epirubicin—ovarian cancer	5.26e-05	0.000457	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—ovarian cancer	5.23e-05	0.000454	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Epirubicin—ovarian cancer	5.22e-05	0.000454	CcSEcCtD
Betamethasone—Fatigue—Epirubicin—ovarian cancer	5.21e-05	0.000453	CcSEcCtD
Betamethasone—Pain—Epirubicin—ovarian cancer	5.17e-05	0.000449	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	5.1e-05	0.000443	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—ovarian cancer	5.06e-05	0.00044	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—ovarian cancer	5.02e-05	0.000436	CcSEcCtD
Betamethasone—Feeling abnormal—Epirubicin—ovarian cancer	4.98e-05	0.000433	CcSEcCtD
Betamethasone—Gastrointestinal pain—Epirubicin—ovarian cancer	4.94e-05	0.00043	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—ovarian cancer	4.92e-05	0.000428	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—ovarian cancer	4.86e-05	0.000423	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.83e-05	0.00042	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—ovarian cancer	4.82e-05	0.000419	CcSEcCtD
Betamethasone—Urticaria—Epirubicin—ovarian cancer	4.8e-05	0.000417	CcSEcCtD
Betamethasone—Pain—Doxorubicin—ovarian cancer	4.78e-05	0.000416	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—ovarian cancer	4.78e-05	0.000415	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—ovarian cancer	4.78e-05	0.000415	CcSEcCtD
Betamethasone—Dexamethasone—ABCB1—ovarian cancer	4.73e-05	0.0322	CrCbGaD
Betamethasone—Feeling abnormal—Doxorubicin—ovarian cancer	4.61e-05	0.000401	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—ovarian cancer	4.57e-05	0.000397	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—ovarian cancer	4.44e-05	0.000386	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—ovarian cancer	4.42e-05	0.000384	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—ovarian cancer	4.42e-05	0.000384	CcSEcCtD
Betamethasone—Asthenia—Epirubicin—ovarian cancer	4.34e-05	0.000377	CcSEcCtD
Betamethasone—Pruritus—Epirubicin—ovarian cancer	4.28e-05	0.000372	CcSEcCtD
Betamethasone—Diarrhoea—Epirubicin—ovarian cancer	4.14e-05	0.000359	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—ovarian cancer	4.01e-05	0.000349	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—ovarian cancer	4e-05	0.000347	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—ovarian cancer	3.96e-05	0.000344	CcSEcCtD
Betamethasone—Vomiting—Epirubicin—ovarian cancer	3.84e-05	0.000334	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—ovarian cancer	3.83e-05	0.000333	CcSEcCtD
Betamethasone—Rash—Epirubicin—ovarian cancer	3.81e-05	0.000331	CcSEcCtD
Betamethasone—Dermatitis—Epirubicin—ovarian cancer	3.81e-05	0.000331	CcSEcCtD
Betamethasone—Headache—Epirubicin—ovarian cancer	3.79e-05	0.000329	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—ovarian cancer	3.7e-05	0.000321	CcSEcCtD
Betamethasone—Nausea—Epirubicin—ovarian cancer	3.59e-05	0.000312	CcSEcCtD
Betamethasone—PGR—Gene Expression—PARP1—ovarian cancer	3.57e-05	0.000678	CbGpPWpGaD
Betamethasone—Vomiting—Doxorubicin—ovarian cancer	3.56e-05	0.000309	CcSEcCtD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	3.55e-05	0.000674	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	3.55e-05	0.000674	CbGpPWpGaD
Betamethasone—Rash—Doxorubicin—ovarian cancer	3.53e-05	0.000306	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	3.52e-05	0.00067	CbGpPWpGaD
Betamethasone—Dermatitis—Doxorubicin—ovarian cancer	3.52e-05	0.000306	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	3.52e-05	0.000669	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	3.51e-05	0.000667	CbGpPWpGaD
Betamethasone—Headache—Doxorubicin—ovarian cancer	3.5e-05	0.000305	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	3.49e-05	0.000663	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	3.48e-05	0.000661	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	3.47e-05	0.00066	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	3.45e-05	0.000655	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	3.45e-05	0.000655	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.44e-05	0.000654	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.43e-05	0.000651	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ESR1—ovarian cancer	3.36e-05	0.000639	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.36e-05	0.000639	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPP1CC—ovarian cancer	3.34e-05	0.000635	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—BRIP1—ovarian cancer	3.34e-05	0.000635	CbGpPWpGaD
Betamethasone—Nausea—Doxorubicin—ovarian cancer	3.32e-05	0.000289	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	3.29e-05	0.000625	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	3.26e-05	0.000619	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HDAC6—ovarian cancer	3.23e-05	0.000613	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	3.05e-05	0.000579	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CAV1—ovarian cancer	2.97e-05	0.000564	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	2.96e-05	0.000562	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	2.95e-05	0.000561	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	2.89e-05	0.00055	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPP2R1A—ovarian cancer	2.89e-05	0.00055	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	2.87e-05	0.000545	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—YAP1—ovarian cancer	2.86e-05	0.000543	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.84e-05	0.000539	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.83e-05	0.000539	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NME2—ovarian cancer	2.81e-05	0.000534	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	2.81e-05	0.000533	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	2.81e-05	0.000533	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.8e-05	0.000532	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—XIAP—ovarian cancer	2.8e-05	0.000532	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.75e-05	0.000523	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.74e-05	0.000521	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SMARCA4—ovarian cancer	2.73e-05	0.000518	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	2.73e-05	0.000518	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.72e-05	0.000517	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CG—ovarian cancer	2.7e-05	0.000514	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PPP1CC—ovarian cancer	2.66e-05	0.000506	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EREG—ovarian cancer	2.66e-05	0.000506	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.66e-05	0.000505	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—ovarian cancer	2.63e-05	0.0005	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYTB—ovarian cancer	2.55e-05	0.000485	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.55e-05	0.000485	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—YAP1—ovarian cancer	2.54e-05	0.000483	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.51e-05	0.000478	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.5e-05	0.000475	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.49e-05	0.000474	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	2.46e-05	0.000467	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	2.44e-05	0.000464	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.43e-05	0.000462	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.43e-05	0.000462	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.41e-05	0.000458	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CD—ovarian cancer	2.38e-05	0.000452	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	2.36e-05	0.000448	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.35e-05	0.000446	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PARP1—ovarian cancer	2.32e-05	0.000441	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.28e-05	0.000432	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.24e-05	0.000427	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—YAP1—ovarian cancer	2.24e-05	0.000426	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPP1CC—ovarian cancer	2.23e-05	0.000424	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BRIP1—ovarian cancer	2.23e-05	0.000424	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PGR—ovarian cancer	2.22e-05	0.000421	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.22e-05	0.000421	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—ovarian cancer	2.21e-05	0.000421	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	2.16e-05	0.00041	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.12e-05	0.000403	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CB—ovarian cancer	2.07e-05	0.000394	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PARP1—ovarian cancer	2.06e-05	0.000392	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ESR1—ovarian cancer	2.05e-05	0.000389	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HDAC6—ovarian cancer	2.02e-05	0.000384	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.01e-05	0.000381	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.95e-05	0.000371	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.95e-05	0.000371	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.95e-05	0.00037	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.91e-05	0.000363	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.91e-05	0.000363	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PPP2R1A—ovarian cancer	1.88e-05	0.000357	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—FASN—ovarian cancer	1.83e-05	0.000347	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.82e-05	0.000345	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYTB—ovarian cancer	1.81e-05	0.000344	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.81e-05	0.000344	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.8e-05	0.000343	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MAPK3—ovarian cancer	1.8e-05	0.000342	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC5A5—ovarian cancer	1.8e-05	0.000341	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—ovarian cancer	1.79e-05	0.00034	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.77e-05	0.000337	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.75e-05	0.000333	CbGpPWpGaD
Betamethasone—PTGS2—Disease—XIAP—ovarian cancer	1.75e-05	0.000333	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—ovarian cancer	1.75e-05	0.000332	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC2A1—ovarian cancer	1.73e-05	0.00033	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NME2—ovarian cancer	1.73e-05	0.000329	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.72e-05	0.000328	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.71e-05	0.000325	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SMARCA4—ovarian cancer	1.71e-05	0.000324	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.7e-05	0.000323	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	1.67e-05	0.000318	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EREG—ovarian cancer	1.66e-05	0.000316	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.66e-05	0.000316	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1B1—ovarian cancer	1.66e-05	0.000316	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.66e-05	0.000315	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.63e-05	0.000309	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.6e-05	0.000305	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BRIP1—ovarian cancer	1.58e-05	0.000301	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.58e-05	0.000301	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.5e-05	0.000286	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—YAP1—ovarian cancer	1.5e-05	0.000284	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TERT—ovarian cancer	1.49e-05	0.000284	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.48e-05	0.000281	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	1.47e-05	0.00028	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.47e-05	0.000279	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FASN—ovarian cancer	1.46e-05	0.000277	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PARP1—ovarian cancer	1.45e-05	0.000276	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.42e-05	0.00027	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC2A1—ovarian cancer	1.38e-05	0.000263	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.38e-05	0.000263	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CAV1—ovarian cancer	1.38e-05	0.000263	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCB1—ovarian cancer	1.37e-05	0.00026	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.35e-05	0.000257	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.35e-05	0.000257	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.35e-05	0.000257	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TYMS—ovarian cancer	1.34e-05	0.000256	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ESR1—ovarian cancer	1.33e-05	0.000253	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6ST—ovarian cancer	1.31e-05	0.000249	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.3e-05	0.000247	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	1.28e-05	0.000243	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.28e-05	0.000243	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—ovarian cancer	1.26e-05	0.00024	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—ovarian cancer	1.26e-05	0.000239	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APC—ovarian cancer	1.26e-05	0.000239	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—FASN—ovarian cancer	1.22e-05	0.000232	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—ovarian cancer	1.21e-05	0.000231	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC5A5—ovarian cancer	1.2e-05	0.000228	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR1—ovarian cancer	1.18e-05	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PPP2R1A—ovarian cancer	1.18e-05	0.000224	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.17e-05	0.000223	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC2A1—ovarian cancer	1.16e-05	0.00022	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.14e-05	0.000216	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.13e-05	0.000216	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYTB—ovarian cancer	1.11e-05	0.000212	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1B1—ovarian cancer	1.11e-05	0.000211	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CD—ovarian cancer	1.11e-05	0.00021	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAPK3—ovarian cancer	1.1e-05	0.000208	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAV1—ovarian cancer	1.08e-05	0.000206	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—ovarian cancer	1.07e-05	0.000202	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—YAP1—ovarian cancer	1.06e-05	0.000202	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.04e-05	0.000197	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—ovarian cancer	1.03e-05	0.000196	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—ovarian cancer	9.87e-06	0.000188	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPP2R1A—ovarian cancer	9.85e-06	0.000187	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.81e-06	0.000186	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—ovarian cancer	9.77e-06	0.000186	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.74e-06	0.000185	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.74e-06	0.000185	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CB—ovarian cancer	9.65e-06	0.000183	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MTOR—ovarian cancer	9.65e-06	0.000183	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.59e-06	0.000182	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—ovarian cancer	9.35e-06	0.000178	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—ovarian cancer	9.27e-06	0.000176	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCB1—ovarian cancer	9.15e-06	0.000174	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—ovarian cancer	9.05e-06	0.000172	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TYMS—ovarian cancer	8.99e-06	0.000171	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—ovarian cancer	8.87e-06	0.000169	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—ovarian cancer	8.86e-06	0.000168	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CD—ovarian cancer	8.68e-06	0.000165	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FASN—ovarian cancer	8.65e-06	0.000164	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CAV1—ovarian cancer	8.65e-06	0.000164	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—ovarian cancer	8.64e-06	0.000164	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—ovarian cancer	8.55e-06	0.000163	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A5—ovarian cancer	8.51e-06	0.000162	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—ovarian cancer	8.38e-06	0.000159	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—ovarian cancer	8.34e-06	0.000158	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A1—ovarian cancer	8.21e-06	0.000156	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6ST—ovarian cancer	8.2e-06	0.000156	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.88e-06	0.00015	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—ovarian cancer	7.87e-06	0.00015	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CB—ovarian cancer	7.56e-06	0.000144	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—ovarian cancer	7.53e-06	0.000143	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—ovarian cancer	7.45e-06	0.000142	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—ovarian cancer	7.44e-06	0.000141	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—ovarian cancer	7.39e-06	0.00014	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAV1—ovarian cancer	7.24e-06	0.000138	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK3—ovarian cancer	7.12e-06	0.000135	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.98e-06	0.000133	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—ovarian cancer	6.93e-06	0.000132	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CD—ovarian cancer	6.92e-06	0.000132	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.92e-06	0.000131	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK1—ovarian cancer	6.78e-06	0.000129	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—ovarian cancer	6.78e-06	0.000129	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—ovarian cancer	6.6e-06	0.000125	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—YAP1—ovarian cancer	6.54e-06	0.000124	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—ovarian cancer	6.54e-06	0.000124	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—ovarian cancer	6.4e-06	0.000122	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TYMS—ovarian cancer	6.37e-06	0.000121	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK3—ovarian cancer	6.33e-06	0.00012	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—ovarian cancer	6.16e-06	0.000117	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—ovarian cancer	6.11e-06	0.000116	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CB—ovarian cancer	6.03e-06	0.000115	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTOR—ovarian cancer	6.03e-06	0.000115	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—ovarian cancer	5.88e-06	0.000112	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CD—ovarian cancer	5.8e-06	0.00011	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—ovarian cancer	5.69e-06	0.000108	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—ovarian cancer	5.66e-06	0.000108	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—ovarian cancer	5.44e-06	0.000103	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—ovarian cancer	5.35e-06	0.000102	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FASN—ovarian cancer	5.33e-06	0.000101	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.24e-06	9.96e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—ovarian cancer	5.21e-06	9.91e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—ovarian cancer	5.21e-06	9.9e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAV1—ovarian cancer	5.13e-06	9.75e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.06e-06	9.62e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CB—ovarian cancer	5.05e-06	9.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.85e-06	9.22e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—ovarian cancer	4.8e-06	9.13e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.68e-06	8.88e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—ovarian cancer	4.66e-06	8.86e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—ovarian cancer	4.65e-06	8.84e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—ovarian cancer	4.61e-06	8.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK3—ovarian cancer	4.46e-06	8.47e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—ovarian cancer	4.37e-06	8.3e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—ovarian cancer	4.33e-06	8.23e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.3e-06	8.18e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—ovarian cancer	4.27e-06	8.12e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK1—ovarian cancer	4.24e-06	8.06e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—ovarian cancer	4.24e-06	8.05e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CD—ovarian cancer	4.11e-06	7.81e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—ovarian cancer	4e-06	7.61e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCB1—ovarian cancer	4e-06	7.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TYMS—ovarian cancer	3.92e-06	7.46e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—ovarian cancer	3.77e-06	7.16e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—ovarian cancer	3.68e-06	6.99e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.58e-06	6.81e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—ovarian cancer	3.4e-06	6.47e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—ovarian cancer	3.26e-06	6.19e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAV1—ovarian cancer	3.16e-06	6.01e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—ovarian cancer	3.1e-06	5.88e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—ovarian cancer	3.08e-06	5.85e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—ovarian cancer	3e-06	5.71e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.88e-06	5.47e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.53e-06	4.81e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—ovarian cancer	2.52e-06	4.78e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.21e-06	4.19e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.18e-06	4.15e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—ovarian cancer	1.91e-06	3.62e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—ovarian cancer	1.78e-06	3.39e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.35e-06	2.56e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—ovarian cancer	1.1e-06	2.09e-05	CbGpPWpGaD
